Turna Ray
Journalist: Personalized medicine, genomics, cancer @GenomeWeb https://t.co/MJTiedX6Di Managing editor: Precision Medicine Online https://t.co/ZhPdXijId5
Articles
-
2 weeks ago |
precisionmedicineonline.com | Turna Ray
NEW YORK – Two newly minted leaders at the US Food and Drug Administration have drafted a new set of priorities for the agency, including modernizing the review process for drugs and devices and addressing the high cost of treatments.
-
3 weeks ago |
precisionmedicineonline.com | Turna Ray
CHICAGO – Giving Genentech's immunotherapy Tecentriq (atezolizumab) with chemotherapy after surgery allowed more patients with mismatch repair deficient (dMMR) colon cancer to live for three years without experiencing disease relapse than with chemotherapy alone, a study presented at the American Society of Clinical Oncology showed on Sunday.
-
3 weeks ago |
precisionmedicineonline.com | Turna Ray
CHICAGO – Investigational HER3-targeted antibody-drug conjugates and bispecifics showed promising efficacy in heavily pretreated non-small cell lung cancer patients harboring classical EGFR activating mutations and other genomic alterations in research presented at the American Society of Clinical Oncology's annual meeting.
-
2 months ago |
precisionmedicineonline.com | Turna Ray
NEW YORK – Novartis executives assured investors on Tuesday that if the Trump Administration moves ahead with tariffs on pharmaceuticals, this would not materially impact its business in the near term since it is actively working to expand drug manufacturing in the US. During a call to discuss first quarter financials, Novartis CEO Vas Narasimhan said that the near-term impact of potential tariffs is "manageable" and baked into the firm's guidance for the year.
-
2 months ago |
precisionmedicineonline.com | Turna Ray
NEW YORK – GlaxoSmithKline's checkpoint inhibitor Jemperli (dostarlimab) spared 80 percent of patients with earlier-stage solid tumors characterized by mismatch repair deficiency (dMMR) from needing surgery, a study has shown.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 1K
- Tweets
- 3K
- DMs Open
- Yes
RT @MyGeneCounsel: @GenomeWeb @TurnaRay and mGC collaborate on a case series titled "Genetic Testing Challenges." Check out all prior artic…
RT @MyGeneCounsel: T minus one month until the Precision Oncology & Diagnostics Conference held by @GenomeWeb. Register to hear from mGC CE…
RT @eumenes_kardia: A rare occasion: an international conference on Salomon Maimon in Germany. We will celebrate work on the new Maimon com…